Therapeutic Options for Metastatic Breast Cancer
- 28 August 2019
- book chapter
- Published by Springer Nature
- Vol. 1152, 131-172
Abstract
Metastatic breast cancer is the most common cancer in women after skin cancer, with a 5-year survival rate of 26%. Due to its high prevalence, it is important to develop therapies that go beyond those that just provide palliation of symptoms. Currently, there are several types of therapies available to help treat breast cancer including: hormone therapy, immunotherapy, and chemotherapy, with each one depending on both the location of metastases and morphological characteristics. Although technological and scientific advancements continue to pave the way for improved therapies that adopt a targeted and personalized approach, the fact remains that the outcomes of current first-line therapies have not significantly improved over the last decade. In this chapter, we review the current understanding of the pathology of metastatic breast cancer before thoroughly discussing local and systemic therapies that are administered to patients diagnosed with metastatic breast cancer. In addition, our review will also elaborate on the genetic profile that is characteristic of breast cancer as well as the local tumor microenvironment that shapes and promotes tumor growth and cancer progression. Lastly, we will present promising novel therapies being developed for the treatment of this disease.Keywords
This publication has 150 references indexed in Scilit:
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsNature, 2012
- Association Between Treatment With Brachytherapy vs Whole-Breast Irradiation and Subsequent Mastectomy, Complications, and Survival Among Older Women With Invasive Breast CancerJAMA, 2012
- Discovery of small molecule cancer drugs: Successes, challenges and opportunitiesMolecular Oncology, 2012
- SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE)Breast Cancer Research and Treatment, 2012
- The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organsInternational Journal of Cancer, 2011
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- TNF-α/NF-κB/Snail pathway in cancer cell migration and invasionBritish Journal of Cancer, 2010
- The tumor microenvironment and its role in promoting tumor growthOncogene, 2008
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004